Peptide stacks for PCOS, fibroids, and belly fat: what the science says

What did @miaadorabeauty actually say?

The claim is pretty simple: DM her the word 'stack' and she'll tell you exactly what peptides she's taking as a 'mama' dealing with belly fat and loose skin after 40. The caption expands this to cover PCOS, fibroids, perimenopause, and weight loss, and describes it as '100% backed by latest science.' That's a big promise attached to a very short video.

To be fair, she didn't make specific clinical claims in the transcript itself. She didn't say 'this cures loose skin' or 'peptides eliminate belly fat.' What she did do is imply a personal regimen has broad applicability for a range of complex hormonal and metabolic conditions affecting women over 40. That implication deserves scrutiny, especially when it's being funneled into private DMs where no one can fact-check what's actually being said.

Does the science back this up?

It depends entirely on which peptides are in the 'stack,' and that's the problem. Some peptides in common telehealth use have legitimate early-stage research behind them. Others are almost entirely preclinical. Lumping them together as a solution for belly fat, loose skin, PCOS, and fibroids is a stretch the science doesn't support yet.

GHK-Cu, a copper-binding peptide, has demonstrated collagen synthesis activity in fibroblast cell studies (Pickart et al., 2015, Journal of Aging Research), which is relevant to skin elasticity. CJC-1295 and ipamorelin together stimulate growth hormone release, and there is some evidence this can improve body composition in growth hormone-deficient adults (Teichman et al., 2006, Journal of Clinical Endocrinology and Metabolism). But 'some evidence in specific populations' is not the same as 'this will fix your belly fat after 40.' MK-677, an oral growth hormone secretagogue, has shown effects on lean mass but also raises insulin resistance concerns in longer-term use (Nass et al., 2008, Annals of Internal Medicine). Fibroids and PCOS are not outcomes any published peptide research has addressed meaningfully in humans.

What did they get wrong (or right)?

She got the interest right. Women over 40 navigating perimenopause, body composition changes, and skin laxity are genuinely underserved by conventional medicine, and peptide therapy is a legitimate emerging area of research. That's real. The problem is the framing.

Describing a personal peptide regimen as applicable to fibroids and PCOS is inaccurate. Fibroids are estrogen-sensitive benign tumors. PCOS involves insulin resistance, androgen excess, and ovulatory dysfunction. Neither condition has a documented peptide treatment protocol in peer-reviewed human trials. Presenting a 'stack' as a solution to both, alongside weight loss and skin tightening, collapses very different biological problems into a single sales pitch. That's misleading regardless of intent.

The DM funnel format also bypasses any real informed consent process. A woman with fibroids acting on supplement or peptide advice from an Instagram DM without physician oversight is taking on real risk, particularly if peptides affect hormone pathways.

What should you actually know?

If you're over 40 and struggling with body composition or skin changes, some peptides are worth a real conversation with a licensed provider. GHK-Cu for skin has a reasonable evidence base for topical use. Growth hormone secretagogues like CJC-1295 and ipamorelin have plausible mechanisms for body composition support, but require lab work, physician oversight, and honest discussion of risks including potential effects on blood sugar and cortisol.

What you should not do is treat a TikTok DM as a clinical consultation. The conditions listed in this caption, including PCOS and fibroids, require diagnosis, hormonal workup, and individualized care. A peptide stack that helped one person lose weight postpartum may be irrelevant or contraindicated for someone with a different hormonal profile. Regulated telehealth platforms exist precisely to give people access to these conversations with actual clinicians, not influencers working from personal experience.

The '100% backed by latest science' claim in the caption is simply not accurate for the full range of conditions listed. Some mechanisms have research support. Most applications in this context do not.